Brookline Capital Markets Initiates a Buy Rating on Kura Oncology (KURA)
Brookline Capital Markets analyst Leah R. Cann initiated coverage with a Buy rating on Kura Oncology (KURA – Research Report) on February 24 and set a price target of $40.00. The company’s More »
Analysts Are Bullish on These Healthcare Stocks: Karuna Therapeutics (KRTX), Sensus Healthcare (SRTS)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Karuna Therapeutics (KRTX – Research Report) and Sensus Healthcare (SRTS – Research Report) with More »
-
Tech
-
Analysts Are Bullish on These Technology Stocks: Axon Enterprise (AXON), Twitter (TWTR)
There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Read More » -
Analysts Are Bullish on These Technology Stocks: Workday (WDAY), Farfetch (FTCH)
There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Read More »
-
-
Industrial Goods
-
ATB Capital Markets Believes Stantec (NYSE: STN) Still Has Room to Grow
In a report released yesterday, AltaCorp Captial from ATB Capital Markets maintained a Buy rating on Stantec (STN Read More » -
Oppenheimer Believes SPX (NYSE: SPXC) Won’t Stop Here
Oppenheimer analyst Bryan Blair assigned a Buy rating to SPX (SPXC – Research Report) yesterday and set a Read More »
-
-
Financial
-
Cormark Securities Believes National Bank of Canada (Other OTC: NTIOF) Won’t Stop Here
In a report released yesterday, Cormark from Cormark Securities upgraded National Bank of Canada (NTIOF – Research Report) Read More » -
Analysts’ Top Financial Picks: Ashford Hospitality (AHT)
Analysts fell to the sidelines weighing in on and Ashford Hospitality (AHT – Research Report) with neutral ratings, Read More »
-
-
Healthcare
-
Friday’s Midday Movers: Aerie Pharma (AERI), Plug Power (PLUG), Intercept Pharma (ICPT), Groupon (GRPN), Civeo (CVEO)
So far Friday, February 26, NASDAQ is up 3.46% and the S&P is up 0.75%. Here are this Read More » -
Why Did Mizuho Securities Downgrade SAGE Therapeutics’ Stock?
SAGE Therapeutics (SAGE – Research Report) received a Hold rating and an $81.00 price target from Mizuho Securities Read More »
-
-
Consumer Goods
-
Diageo (DGEAF) Gets a Hold Rating from RBC Capital
In a report released yesterday, James Edwardes Jones from RBC Capital maintained a Hold rating on Diageo (DGEAF Read More » -
The EVP, Res, Dev & Qlty of Mondelez International (NASDAQ: MDLZ) is Selling Shares
Yesterday, the EVP, Res, Dev & Qlty of Mondelez International (MDLZ – Research Report), Robin Hargrove, sold shares Read More »
-
-
Services
-
Saturday’s Midday Stock Update: Monitronics International (SCTY), Aerie Pharma (AERI), Groupon (GRPN), Intercept Pharma (ICPT), La Jolla Pharma (LJPC)
So far Saturday, February 27, NASDAQ is down -2.47% and the S&P is down -4.34%. Here are this Read More » -
Dolby Laboratories (DLB) Gets a Buy Rating from Tigress Financial
In a report released yesterday, Ivan Feinseth from Tigress Financial reiterated a Buy rating on Dolby Laboratories (DLB Read More »
-